BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35812007)

  • 21. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
    Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
    Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.
    Seshadri RA; Glehen O
    Indian J Surg Oncol; 2016 Jun; 7(2):198-207. PubMed ID: 27065710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for the prevention and control of peritoneal metastasis in patients with gastrointestinal malignancies: a systematic review of randomized controlled trials.
    Dominic JL; Kannan A; Tara A; Hakim Mohammed AR; Win M; Khorochkov A; Sultan W; Ahmed A; Kantamaneni K; Syzmanski MW; Singh R; Marquez RA; Asarian A; Thirunavukarasu P; Keckeisen G
    EXCLI J; 2021; 20():1328-1345. PubMed ID: 34650387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.
    Huang CQ; Min Y; Wang SY; Yang XJ; Liu Y; Xiong B; Yonemura Y; Li Y
    Oncotarget; 2017 Aug; 8(33):55657-55683. PubMed ID: 28903452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Acs M; Babucke M; Jusufi M; Kaposztas Z; Slowik P; Hornung M; Schlitt HJ; Panczel I; Hevesi J; Herzberg J; Strate T; Piso P
    Innov Surg Sci; 2024 Mar; 9(1):3-15. PubMed ID: 38826635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: A systematic review of literature.
    Matsuzaki S; Matsuzaki S; Chang EJ; Yasukawa M; Roman LD; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):70-77. PubMed ID: 33419612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
    World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.
    van Stein RM; Aalbers AGJ; Sonke GS; van Driel WJ
    JAMA Oncol; 2021 Aug; 7(8):1231-1238. PubMed ID: 33956063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X
    BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies.
    Morris MC; Cloyd JM; Hays J; Patel SH
    J Gastrointest Surg; 2021 Jan; 25(1):303-318. PubMed ID: 32808135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.
    Mirnezami R; Moran BJ; Harvey K; Cecil T; Chandrakumaran K; Carr N; Mohamed F; Mirnezami AH
    World J Gastroenterol; 2014 Oct; 20(38):14018-32. PubMed ID: 25320542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
    Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
    de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
    Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and future prospects of clinical trials on CRS + HIPEC for gastric cancer peritoneal metastases.
    Ji ZH; Peng KW; Yu Y; Li XB; Yonemura Y; Liu Y; Sugarbaker PH; Li Y
    Int J Hyperthermia; 2017 Aug; 33(5):562-570. PubMed ID: 28124576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer.
    Canbay E; Canbay Torun B; Cosarcan K; Altunal C; Gurbuz B; Bilgic C; Sezgin C; Kaban KK; Yilmaz S; Yazici Z
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S47-S56. PubMed ID: 33968425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum.
    Jain AJ; Badgwell BD
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
    Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D
    Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.